Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
ECG 10s (CHRIS baseline)
x0ec110b
Q-Amplitude, II
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec110c
Q-Amplitude, III
Voltage amplitude of the peak of Q wave, expressed in milliVolts, measured in lead III
Float
ECG 10s (CHRIS baseline)
x0ec121i
R-Amplitude, V3
Voltage amplitude of the peak of R wave, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec123h
R'-Amplitude, V2
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec123l
R'-Amplitude, V6
Voltage amplitude of the peak of R wave in the first derivative of ECG, expressed in milliVolts, measured in lead V6
Float
ECG 10s (CHRIS baseline)
x0ec126d
S-Amplitude, aVR
Voltage amplitude of the peak of S wave, expressed in milliVolts, measured in lead aVR
Float
ECG 10s (CHRIS baseline)
x0ec128i
S'-Amplitude, V3
Voltage amplitude of the peak of S wave in the first derivative of ECG, expressed in milliVolts, measured in lead V3
Float
ECG 10s (CHRIS baseline)
x0ec129j
ST Value, V4
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead V4
Float
ECG 10s (CHRIS baseline)
x0ec131h
J-Value, V2
J point voltage value, expressed in milliVolts, measured in lead V2
Float
ECG 10s (CHRIS baseline)
x0ec143b
Noise, II
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead II
Float
ECG 10s (CHRIS baseline)
x0ec143c
Noise, III
Noise level estimation, when QTc is computed with Fridericia formula, expressed in microVolts, measured in lead III
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec17
Standard deviation (longitudinal or diagonally of the angle bisector) in Poincaré plot
Standard deviation (longitudinal or diagonally of the angle bisector) in Poincaré plot
Float
Flavonoid intake (CHRIS baseline)
x0fl001
Total daily Total flavonoids
Total daily Total flavonoids
Float
Flavonoid intake (CHRIS baseline)
x0fl019
Total daily (+)-Gallocatechin
Total daily (+)-Gallocatechin
Float
Flavonoid intake (CHRIS baseline)
x0fl031
Total daily Theaflavin-3-gallate
Total daily Theaflavin-3-gallate
Float
Nutrient intake (CHRIS baseline)
x0nu004
Total daily Fat
Total daily Fat (g)
Float
Nutrient intake (CHRIS baseline)
x0nu014
Total daily Maltose
Total daily Maltose (g)
Float
Nutrient intake (CHRIS baseline)
x0nu015
Total daily Lactose
Total daily Lactose (g)
Float
Nutrient intake (CHRIS baseline)
x0nu022a
Total daily cis-Mono FA /100g FA
Total daily cis-Mono FA /100g FA (g)
Float
Nutrient intake (CHRIS baseline)
x0nu028b
Total daily Trans FAs /100g food
Total daily Trans FAs /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu039
Total daily Manganese
Total daily Manganese (mg)
Float
Nutrient intake (CHRIS baseline)
x0nu042
Total daily Retinol
Total daily Retinol (µg)
Float
Nutrient intake (CHRIS baseline)
x0nu052
Total daily Niacin equivalent
Total daily Niacin equivalent (mg)
Float
Nutrient intake (CHRIS baseline)
x0nu065
Total daily C12:0 ex Br /100g food
Total daily C12:0 ex Br /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu075
Total daily C17:0 ex Br /100g food
Total daily C17:0 ex Br /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu084
Total daily C24:0 ex Br /100g food
Total daily C24:0 ex Br /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu097
Total daily cis C17:1 /100g food
Total daily cis C17:1 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu109
Total daily cis C24:1 /100g food
Total daily cis C24:1 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu114
Total daily C16:4 /100g food
Total daily C16:4 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu126
Total daily cis n-6 C20:2 /100g food
Total daily cis n-6 C20:2 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu138
Total daily cis n-6 C22:3 /100g food
Total daily cis n-6 C22:3 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu143
Total daily C22:6 /100g food
Total daily C22:6 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu144
Total daily cis n-3 C22:6 /100g food
Total daily cis n-3 C22:6 /100g food (g)
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec03
Standard Deviation of normal-to-normal intervals (SDNN)
Standard Deviation of normal-to-normal intervals (SDNN)
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec07
Percentage of interval differences of successive NN intervals greater than 50 ms (pNN50)
Percentage of interval differences of successive NN intervals greater than 50 ms (pNN50)
Float
Flavonoid intake (CHRIS baseline)
x0fl014
Total daily Malvidin
Total daily Malvidin
Float
Flavonoid intake (CHRIS baseline)
x0fl018
Total daily (+)-Catechin
Total daily (+)-Catechin
Float
Smoking (CHRIS baseline)
x0sm35
Smoking: Cigarettes (current)
How much do you now smoke on average? No. of Cigarettes/day (current)
Float
Smoking (CHRIS baseline)
x0sm60
Cumulative pack-years (past)
Cumulative pack-years (past)
Float
Smoking (CHRIS baseline)
x0sm61
Tobacco (current, all tobacco sources)
Total smoking grams/day (current, all tobacco sources)
Float
Gynecology (CHRIS baseline)
x0wo04b
Use of contraceptive pills
How many months or years have you taken contraceptives?
Float
Iron metabolism (CHRIS baseline)
x0he03
Hepcidin-25
Hepcidin-25
Float
Iron metabolism (CHRIS baseline)
x0he08a
Soluble transferrin receptor concentration, high stringency filter
Soluble transferrin receptor concentration with application of a high stringency filter
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt003
alpha-AAA
alpha-Aminoadipic acid
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt010
Gln
Glutamine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt020
Met-SO
Methioninesulfoxide
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt032
Taurine
Taurine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt042
C12-DC
Dodecanedioylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt043
C12:1
Dodecenoylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt048
C14:2-OH
Hydroxytetradecadienylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt061
C5
Valerylcarnitine
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt072
lysoPC a C14:0
lysoPhosphatidylcholine acyl C14:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt080
lysoPC a C20:4
lysoPhosphatidylcholine acyl C20:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt088
PC aa C28:1
Phosphatidylcholine diacyl C28:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt100
PC aa C36:1
Phosphatidylcholine diacyl C36:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt112
PC aa C40:1
Phosphatidylcholine diacyl C40:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt115
PC aa C40:4
Phosphatidylcholine diacyl C40:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt125
PC ae C30:1
Phosphatidylcholine acyl-alkyl C30:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt137
PC ae C36:4
Phosphatidylcholine acyl-alkyl C36:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt149
PC ae C40:4
Phosphatidylcholine acyl-alkyl C40:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt150
PC ae C40:5
Phosphatidylcholine acyl-alkyl C40:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt169
SM C18:0
Sphingomyeline C18:0
Float
Heart rate variability (CHRIS baseline)
x0ec240
logVLF power (Welch)
Natural logarithm transformed values of VLF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Heart rate variability (CHRIS baseline)
x0ec257
logVLF power (AR)
Natural logarithm transformed values of VLF band, with PSD estimated using parametric autoregressive (AR) modeling method
Float
Heart rate variability (CHRIS baseline)
x0ec263
HF power (%) (AR)
Relative power of HF band, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in ms^2
Float
Heart rate variability (CHRIS baseline)
x0ec274
Correlation Dimension D2
Correlation Dimension D2: it is a method for measuring the complexity or strangeness of the RR series. This index is expected to give information on the minimum number of dynamic variables needed to model the underlying system
Float
Heart rate variability (CHRIS baseline)
x0ec283j
MSE (t=10)
MSE (t=10): Multi Scale Entropy, extension of SampEn to multiple time scales, here calculated for time scale factor equal to 10
Float
ECG 10s (CHRIS baseline)
x0ec105a
P-Amplitude positive, I
Peak amplitude of the positive deflection of P wave, expressed in milliVolts, measured in lead I
Float
ECG 10s (CHRIS baseline)
x0ec129e
ST Value, aVL
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead aVL
Float
ECG 10s (CHRIS baseline)
x0ec129f
ST Value, aVF
ST segment deviation from the isoelectric line, defined as the difference between the voltage value at the beginning of T wave and the end of S wave (J point) expressed in milliVolts, measured in lead aVF
Float
Heart rate variability (CHRIS baseline)
x0ec226
SI (Stress Index)
SI: Baevsky stress index, computed according to the formula given in Baevsky 2009, is a geometric measure of HRV reflecting cardiovascular system stress
Float
Heart rate variability (CHRIS baseline)
x0ec233
VLF peak (Welch)
Very Low Frequency (VLF) band peak frequency, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in Hz
Float
Flavonoid intake (CHRIS baseline)
x0fl020
Total daily (-)-Epicatechin
Total daily (-)-Epicatechin
Float
Nutrient intake (CHRIS baseline)
x0nu019b
Total daily Satd FA /100g food
Total daily Satd FA /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu076
Total daily C18:0 /100g food
Total daily C18:0 /100g food (g)
Float
Heart rate variability (CHRIS baseline)
x0ec247
LF power (n.u.) (Welch)
Power of LF band in normalised units, LF [n.u.] = LF [ms2] / (total power [ms2] - VLF [ms2]) x 100%, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in n.u
Float
Heart rate variability (CHRIS baseline)
x0ec281
RPA Lmean
RPA Lmean: Recurrence Plot Analysis is another approach for analyzing the complexity of the RR series, which consists in creating a symmetrical matrix of zeros and ones. Lmean is the average diagonal line length
Float
Sleep quality (CHRIS baseline)
x0sq04a
4. During the past month, how many hours of actual sleep did you get at night?
During the past month, how many hours of actual sleep did you get at night? (This may be different than the number of hours you spent in bed.)
Float
Urine measurements (CHRIS baseline)
x0lp56
Hemoglobin, urine
Hemoglobin, urine
Float
Heart rate variability (CHRIS baseline)
x0ec230
DC
DC: Deceleration Capacity is a measure of cardiac parasympathetic modulation as it captures the lengthening of RR interval within 2-4 successive beats. It is computed as a four point difference from the deceleration PRSA signal (phase-rectified signal averaging), expressed in milliseconds
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt152
PC ae C42:0
Phosphatidylcholine acyl-alkyl C42:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt153
PC ae C42:1
Phosphatidylcholine acyl-alkyl C42:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt154
PC ae C42:2
Phosphatidylcholine acyl-alkyl C42:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt155
PC ae C42:3
Phosphatidylcholine acyl-alkyl C42:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt156
PC ae C42:4
Phosphatidylcholine acyl-alkyl C42:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt157
PC ae C42:5
Phosphatidylcholine acyl-alkyl C42:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt158
PC ae C44:3
Phosphatidylcholine acyl-alkyl C44:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt159
PC ae C44:4
Phosphatidylcholine acyl-alkyl C44:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt160
PC ae C44:5
Phosphatidylcholine acyl-alkyl C44:5
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt161
PC ae C44:6
Phosphatidylcholine acyl-alkyl C44:6
Float
Chronic diseases (CHRIS baseline)
x0cd01b
Liver disease (age at diagnosis)
In which year was it diagnosed for the first time? (age at diagnosis)
Integer
Alcohol (CHRIS baseline)
x0al06b
Start drinking regularly
When did you start drinking regularly alcohol?
Integer
Alcohol (CHRIS baseline)
x0al03a
Alcohol consumption (weekend): Alcohol-free beer
During the last 12 months, how many of the following beverages have you usually drunk on a weekend (Friday, Saturday, Sunday)? Alcohol-free beer (No. of glasses a 0.2 I)
Integer
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec59
Ventricular runs
No. of ventricular runs
Integer
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec46
Supraventricular runs
No. of supraventricular runs
Integer
ECG 10s (CHRIS baseline)
x0ec153e
QTc (Baz) Time, aVL
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead aVL
Integer
ECG 10s (CHRIS baseline)
x0ec151a
QTc (Frid) Dispersion
QTc dispersion is defined as the difference between the longest and the shortest QTc duration (with Fridericia formula) measured in the 12 ECG leads, expressed in milliseconds
Integer
Neurological phenotypes (CHRIS baseline)
x0nd0008a
Multisite Chronic Pain by number of body sites
Multisite Chronic Pain by number of body sites
Integer
ECG 10s (CHRIS baseline)
x0ec153h
QTc (Baz) Time, V2
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead V2
Integer
ECG 10s (CHRIS baseline)
x0ec153f
QTc (Baz) Time, aVF
Duration of QT interval adjusted for the heart-rate with Bazett formula, expressed in milliseconds, measured in lead aVF
Integer
Previous
1
34
35
36
37
38
43
Next